Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Nodality Snags Pfizer Deal to Improve Autoimmune R&D, Diagnostics
Aug. 10, 2012
South San Francisco-based Nodality has spent five years honing an enabling technology for personalized medicine, which could help patients avoid wasteful treatments and improve the success rate in new drug R&D. Now it has persuaded New York-based Pfizer, the world’s biggest drugmaker, to buy into its vision.
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing